New CEO in Navamedic ASA

07-May-2009 - Norway

Olof Milveden is appointed new CEO of Navamedic ASA. Olof Milveden has 27 years of experience from the pharma/health care industry. His last position has been that of CEO and Cluster Head Nordic in Sandoz A/S (Denmark). He has working experience from Europe, Asia, Africa and USA. Previous positions have been among others; Regional Manager, Asia Pacific for Merck Pharmaceuticals, Managing Director Merck Generics Nordic, Managing Director South Africa in Merck Pharmaceuticals. He has also held a Swedish diplomatic post as the Trade commissioner to India and he has had leading positions in smaller companies such as Organon Teknika Sweden.

Olof Milveden is 56 years and from Sweden. He will have his office in Gothenburg and started in the position as CEO on 4 May.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances